Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HIV/AIDS: early-phase trial registry
15 of 62 indexed HIV/AIDS trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #228 of 28,707 conditions by registered trial count.
62 US clinical trials · 15 currently recruiting · #228 of 28,707 conditions by registered trial count
HIV/AIDS: 62 US clinical trials tracked, 15 recruiting.
HIV/AIDS is the subject of 62 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 7 of these trials.
Enrollment posture brief
Registry condition hivaids
OPEN 15 | RECR 24% | LATE 1 | EARLY 8 | RANK #228 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Myopia (24% recruiting · 91 trials)
HIV/AIDS lists 15 open slots (24% of 62 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HIV/AIDS on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HIV/AIDS is recruiting below its size-band peers.
15 of 62 indexed trials (24.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of HIV/AIDS trials is spread across many organizations.
University of California, San Francisco accounts for 7 of 62 trials (11.3%). 38 distinct sponsors appear on at least one study for this condition label.
-
Typical HIV/AIDS enrolment sits around 141 participants.
Median target enrolment is 141 among the 62 trials that report a genuine target (sentinel values excluded). 25 of those (40.3%) plan for fewer than 100 participants.
-
HIV/AIDS research is mostly interventional.
53 interventional and 9 observational studies make up this index (85.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
62 total, page 1 of 2
Observational Pharmaco-Epidemiology Research & Analysis
Epividian
NCT03813862
MyPEEPS LITE Trial
Columbia University
NCT06741631
Improving the Organizational Social Context to Address Structural Racism and Discrimination
University of Pennsylvania
NCT06462807
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
Columbia University
NCT06741618
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
Columbia University
NCT06472206
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Columbia University
NCT03135886
Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement
University of California, San Diego
NCT05509959
Optimizing Tobacco Use Treatment for PLWHA
University of Pennsylvania
NCT04176172
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Massachusetts General Hospital
NCT06274632
A Mobile Gaming App to Improve Adherence to PrEP
Rhode Island Hospital
NCT05762705
Appalachian Partnership to Reduce Disparities (Aim 2)
Wake Forest University Health Sciences
NCT04378439
An Integrated Intervention Using a Pill Ingestible Sensor System
University of California, Los Angeles
NCT06480578
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
University of Miami
NCT03738410
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
Guiding Right
NCT06458660
SCOPE Analytic Treatment Interruption Protocol
University of California, San Francisco
NCT04359186
ResIlience-based Stigma REdUction Program ("Rise-up")
University of South Carolina
NCT05174936
Intervention for Virologic Suppression in Youth
University of California, San Francisco
NCT05877729
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Case Western Reserve University
NCT04019197
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
VA Eastern Colorado Health Care System
NCT03729778
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
Johns Hopkins University
NCT04298905
Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana
University of Pennsylvania
NCT04488250
Combinatorial Therapy to Induce an HIV Remission
University of California, San Francisco
NCT04357821
HIV Jail POC-AgAB Testings
Montefiore Medical Center
NCT04296331
Theory-based HIV Disclosure Intervention for Parents
University of South Carolina
NCT04051177
PositiveLinks: mHealth for DC Cohort
George Washington University
NCT04998019
Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care
University of California, Los Angeles
NCT02310893
Behavioral Intervention to Enhance HIV Test/Treat
University of Connecticut
NCT01752777
Integrating HIV and Hepatitis C Screening in an Urban Emergency Department
New York City Health and Hospitals Corporation
NCT03252483
Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)
Johns Hopkins University
NCT03934437
COVID-19 in Patients With HIV
University of Missouri-Columbia
NCT04333953
Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite
Harvard School of Public Health (HSPH)
NCT03279185
A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans
RAND
NCT03331978
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
Case Western Reserve University
NCT03643705
Duo Partnership Adherence Commitment Therapy
University of California, San Francisco
NCT02925949
MEMO-Medical Marijuana and Opioids Study
Albert Einstein College of Medicine
NCT03268551
ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction
University of Wisconsin, Madison
NCT03873129
CASA: Care and Support Access in HIV Disease
University of Maryland
NCT02136680
Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain
New York University
NCT03855111
Prevention and Risk: Treatment With a New Emphasis on Relationships
Hunter College of City University of New York
NCT03396367
Developing and Examining Evidenced-Based HIV Testing Messages
Virginia Commonwealth University
NCT03433053
Project RAP: Family-based HIV Prevention in the Juvenile Drug Court
University of California, San Francisco
NCT01403298
iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV
University of California, San Diego
NCT03123731
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
University of Arkansas
NCT04064567
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development
Hektoen Institute for Medical Research
NCT04077138
Enhancing Sexual Safety: Couples' Communication and HIV Testing Among YMSM
Florida State University
NCT04289116
PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDS
Dimagi
NCT03758066
Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
VA Eastern Colorado Health Care System
NCT01749007
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study
Hektoen Institute for Medical Research
NCT03652623
Development of a Couple-Based Mobile Health Intervention for Enhancing HIV Care Engagement Outcomes (N'Gage)
University of California, San Francisco
NCT03100643
Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis Regimens
Emory University
NCT03976752
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on HIV/AIDS records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HIV/AIDS trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HIV/AIDS page
62 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 HIV/AIDS trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, San Francisco sponsors the most HIV/AIDS trials on record, review their full trial history before evaluating a specific study. See University of California, San Francisco's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HIV/AIDS condition card totals 62 registered trials; most-linked intervention Peer Navigation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.